SMID Cap Biopharma Trades for the next 4 Months
SMID Biopharma FOCUS Trades for the Next Move Up Seasonality and technicals favor SMID Cap Biotech through July: ASCO,M&A. Needs support from sector trades in overall market : IWM up 12.93% YTD, XBI, IBB and Large cap Biopharma earnings. Geopolitical backdrop is not a factor except for lack...
Trending Towards Risk Off with Healthcare and Biotech Stocks…Update-3 Risk ON
Update-3... 5/1/26 ..After such big moves in the market this could be a good time to enjoy your profits and review your portfolio . Here are several SMID cap biotech stocks that we own, are in the money but poised for more gains: ABSI, ABOS, AXSM, COGT, ILMN, RCUS, XENE, XNCR. Small caps lagged...
What Is a Balanced Portfolio: Are You a Trader or an Investor?…Update-3
Update -3 Get ready for SMID cap biotech Q2/Q3 rally, historically strong because of ASCO. Here are several SMID stocks on our trading list that have made huge gains YTD with the XBI up 4.76%: APLs up 60%, CBIO up 55%, DNLI up 16%, DNTH up 103%, PTGX up 20%, SLDB up 27%, TWST up 49%, XENE up...
Healthcare Sector Snapshot- M&A Will Drive SMID Cap Biopharma now in a Rally Mode…Update-2…”Strait talk”
Update-2 4/17/26...When the market is up because oil is down and the Straits may be open soon what can we say? A green screen day in SMID biopharma. Added to Illumina (ILMN) long at $132, Bought options in ABT stock believing that stock will come back by year end well over $105. Small...
SMID Biotech Stocks Update to our Trading Model with BULL Market Intact…Update-2
Update-2 4/12/26...Will try to focus on Diagnosiics and Tools this week as Healthcare looked weak.. Hope for some clarity from Abbott (ABT) down 19.95% YTD, on Thursday. Look at Fidelity FSMEX down 27.3% YTD down 22% 1 yr. TMO a favorite, for many years down 14.38% YTD, up 16% one year. BUT I...